Condition: Acute Ischemic Stroke · Atrial Fibrillation · Sponsor: Universitätsklinikum Hamburg-Eppendorf
This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.
This description comes directly from the study's public registry record.
Märit Jensen, MD · +4940741053770 · m.jensen@uke.de
Götz Thomalla, MD · +4940741050137 · thomalla@uke.de
Always discuss trial participation with your own doctor first.
| University Medical Center Hamburg-Eppendorf | Hamburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05293080